Axogen, Inc. — Director's Dealing 2022

Dec 29, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-12-27

Reporting Person: DeVinney Erick Wayne (VP Peripheral Nerve Science)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-27	Common Stock	M	20000	$5.09	Acquired	116752	Direct
2022-12-27	Common Stock	F	10784	$9.44	Disposed	105968	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-27	Employee Stock Option (right to buy)	$5.09	M	20000	Disposed	2022-12-28	Common Stock (20000.0)	Direct

Footnotes

F1: This Form is being filed to report the exercise of a stock option for a total of 20,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock, the Reporting Person, on a net basis, acquired ownership of an additional 9,216 shares of common stock.